These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 16099011

  • 1. Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand.
    Onlamoon N, Tabprasit S, Suwanagool S, Louisirirotchanakul S, Ansari AA, Pattanapanyasat K.
    Virology; 2005 Oct 25; 341(2):238-47. PubMed ID: 16099011
    [Abstract] [Full Text] [Related]

  • 2. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E, Al Tabaa Y, Baillat V, Segondy M, Picot MC, Reynes J, Vendrell JP.
    Cytometry B Clin Cytom; 2009 Jul 25; 76(4):249-60. PubMed ID: 19072838
    [Abstract] [Full Text] [Related]

  • 3. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M, Cordero M, Almeida J, Orfao A.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):22-33. PubMed ID: 17051525
    [Abstract] [Full Text] [Related]

  • 4. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort.
    Glencross DK, Janossy G, Coetzee LM, Lawrie D, Scott LE, Sanne I, McIntyre JA, Stevens W.
    Cytometry B Clin Cytom; 2008 Jan 15; 74 Suppl 1():S131-40. PubMed ID: 18228566
    [Abstract] [Full Text] [Related]

  • 5. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A, John L, Shamji MH, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.
    HIV Med; 2008 Feb 15; 9(2):118-25. PubMed ID: 18257774
    [Abstract] [Full Text] [Related]

  • 6. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 7. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O, Holub M, Spála J, Kalanin J, Stanková M.
    Acta Virol; 2003 Jan 15; 47(2):121-4. PubMed ID: 14524479
    [Abstract] [Full Text] [Related]

  • 8. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA.
    AIDS; 2008 Oct 01; 22(15):1937-41. PubMed ID: 18784457
    [Abstract] [Full Text] [Related]

  • 9. From research tool to routine test: CD38 monitoring in HIV patients.
    Coetzee LM, Tay SS, Lawrie D, Janossy G, Glencross DK.
    Cytometry B Clin Cytom; 2009 Nov 01; 76(6):375-84. PubMed ID: 19422053
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.
    Antivir Ther; 2007 Nov 01; 12(6):971-5. PubMed ID: 17926652
    [Abstract] [Full Text] [Related]

  • 11. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
    Echaniz P, Arrizabalaga J, Iribarren JA, Cuadrado E.
    Cell Immunol; 1993 Aug 01; 150(1):72-80. PubMed ID: 7688270
    [Abstract] [Full Text] [Related]

  • 12. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
    Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V.
    J Infect Dis; 2005 Dec 15; 192(12):2142-6. PubMed ID: 16288380
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 14. Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients.
    Kaushik S, Vajpayee M, Sreenivas V, Seth P.
    Clin Immunol; 2006 Jun 13; 119(3):330-8. PubMed ID: 16476571
    [Abstract] [Full Text] [Related]

  • 15. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L, Navarro J, Carbone J, Rodríguez-Sáinz C, Gil J, López F, Fernández-Cruz E, STIR-2102 Team.
    Vaccine; 2008 May 23; 26(22):2738-45. PubMed ID: 18433946
    [Abstract] [Full Text] [Related]

  • 16. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.
    J Infect Dis; 2006 Jul 01; 194(1):29-37. PubMed ID: 16741879
    [Abstract] [Full Text] [Related]

  • 17. Immunologic features of HIV-1-infected women on HAART at delivery.
    Ono E, Dos Santos AM, Machado DM, Succi RC, Amed AM, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2008 Jul 01; 74(4):236-43. PubMed ID: 18393385
    [Abstract] [Full Text] [Related]

  • 18. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation.
    Wang Y, Liu Y, Han R, Li Q, Yao Z, Niu W, Yuan Y, Tang Z, Zhu Z, Shen Z.
    J Gastroenterol Hepatol; 2010 Jan 01; 25(1):138-42. PubMed ID: 19817952
    [Abstract] [Full Text] [Related]

  • 19. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
    Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K.
    AIDS; 2006 Apr 04; 20(6):813-20. PubMed ID: 16549964
    [Abstract] [Full Text] [Related]

  • 20. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ, Begovac J, Vince A.
    FEMS Immunol Med Microbiol; 2006 Apr 04; 46(3):351-9. PubMed ID: 16553807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.